Form 8-K - Current report:
SEC Accession No. 0001493152-22-018455
Filing Date
2022-07-05
Accepted
2022-07-05 08:17:04
Documents
29
Period of Report
2022-07-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42832
2 ex99-1.htm EX-99.1 11805
3 ex99-2.htm EX-99.2 25036
4 ex99-1_001.jpg GRAPHIC 109430
5 ex99-1_002.jpg GRAPHIC 661677
6 ex99-1_003.jpg GRAPHIC 234179
7 ex99-1_004.jpg GRAPHIC 373411
8 ex99-1_005.jpg GRAPHIC 273360
9 ex99-1_006.jpg GRAPHIC 274569
10 ex99-1_007.jpg GRAPHIC 246191
11 ex99-1_008.jpg GRAPHIC 240510
12 ex99-1_009.jpg GRAPHIC 243354
13 ex99-1_010.jpg GRAPHIC 224314
14 ex99-1_011.jpg GRAPHIC 362125
15 ex99-1_012.jpg GRAPHIC 231670
16 ex99-1_013.jpg GRAPHIC 231857
17 ex99-1_014.jpg GRAPHIC 200209
18 ex99-2_001.jpg GRAPHIC 5389
  Complete submission text file 0001493152-22-018455.txt   5652993

Data Files

Seq Description Document Type Size
19 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aneb-20220705.xsd EX-101.SCH 2956
20 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aneb-20220705_lab.xml EX-101.LAB 34240
21 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aneb-20220705_pre.xml EX-101.PRE 22357
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3735
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40388 | Film No.: 221063241
SIC: 2834 Pharmaceutical Preparations